tiprankstipranks
Advertisement
Advertisement

HK:1011 Stock Latest News

China NT Pharma Delays Shareholder Circular on Loan Capitalisation
Company AnnouncementsChina NT Pharma Delays Shareholder Circular on Loan Capitalisation
1d ago
1011
China NT Pharma Proposes New Auditor CCTH CPA After Moore’s Retirement
PremiumCompany Announcements
China NT Pharma Proposes New Auditor CCTH CPA After Moore’s Retirement
4d ago
1011
China NT Pharma Names New CEO as Leadership Shifts to Next Generation
PremiumCompany Announcements
China NT Pharma Names New CEO as Leadership Shifts to Next Generation
8d ago
1011
China NT Pharma Tightens Controls After Review Flags Gaps in Connected Transactions
PremiumCompany Announcements
China NT Pharma Tightens Controls After Review Flags Gaps in Connected Transactions
8d ago
1011
China NT Pharma to Capitalise Debts via Major Share Issue to Connected Creditors
PremiumCompany Announcements
China NT Pharma to Capitalise Debts via Major Share Issue to Connected Creditors
24d ago
1011
China NT Pharma Discloses Auditor’s Retirement and Plans to Appoint Successor
PremiumCompany AnnouncementsChina NT Pharma Discloses Auditor’s Retirement and Plans to Appoint Successor
30d ago
1011
China NT Pharma Shareholders Reject Auditor but Approve Capital Mandates at AGM
Premium
Company Announcements
China NT Pharma Shareholders Reject Auditor but Approve Capital Mandates at AGM
1M ago
1011
China NT Pharma Explores Sale of Overseas Unit to Ease Liquidity Strain
Premium
Company Announcements
China NT Pharma Explores Sale of Overseas Unit to Ease Liquidity Strain
1M ago
1011
China NT Pharma Discloses Governance Dispute Behind Director’s Resignation
PremiumCompany Announcements
China NT Pharma Discloses Governance Dispute Behind Director’s Resignation
2M ago
1011
China NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen
PremiumCompany Announcements
China NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen
2M ago
1011
China NT Pharma details board and committee structure
PremiumCompany Announcements
China NT Pharma details board and committee structure
2M ago
1011
China NT Pharma Reveals Past Unannounced Connected Transactions and Compliance Lapses
PremiumCompany Announcements
China NT Pharma Reveals Past Unannounced Connected Transactions and Compliance Lapses
2M ago
1011
China NT Pharma Reshapes Audit Oversight with New Independent Director
PremiumCompany AnnouncementsChina NT Pharma Reshapes Audit Oversight with New Independent Director
2M ago
1011
China NT Pharma Advances AI Health Pivot as It Negotiates Debt Restructuring
Premium
Company Announcements
China NT Pharma Advances AI Health Pivot as It Negotiates Debt Restructuring
2M ago
1011
China NT Pharma Calls 2026 AGM, Seeks Renewal of Share Issuance Mandate
Premium
Company Announcements
China NT Pharma Calls 2026 AGM, Seeks Renewal of Share Issuance Mandate
2M ago
1011
China NT Pharma Names Major Shareholder Lou Yongbin as Non-Executive Director to Support AI Healthcare Pivot
PremiumCompany Announcements
China NT Pharma Names Major Shareholder Lou Yongbin as Non-Executive Director to Support AI Healthcare Pivot
3M ago
1011
China NT Pharma Narrows Annual Loss Despite Revenue Decline in 2025
PremiumCompany Announcements
China NT Pharma Narrows Annual Loss Despite Revenue Decline in 2025
3M ago
1011
China NT Pharma Narrows Expected 2025 Loss on One-Off Debt-Settlement Gain
PremiumCompany Announcements
China NT Pharma Narrows Expected 2025 Loss on One-Off Debt-Settlement Gain
3M ago
1011
China NT Pharma Completes Share-Financed Acquisition and Reshapes Shareholding Structure
PremiumCompany Announcements
China NT Pharma Completes Share-Financed Acquisition and Reshapes Shareholding Structure
4M ago
1011
China NT Pharma Sets March 31 Board Meeting to Approve 2025 Results and Consider Dividend
PremiumCompany AnnouncementsChina NT Pharma Sets March 31 Board Meeting to Approve 2025 Results and Consider Dividend
4M ago
1011
China NT Pharma Flags Sharply Narrower 2025 Loss Driven by Fair Value Gains
Premium
Company Announcements
China NT Pharma Flags Sharply Narrower 2025 Loss Driven by Fair Value Gains
5M ago
1011
China NT Pharma Drops Convertible Bond Plan, Trading to Resume
Premium
Company Announcements
China NT Pharma Drops Convertible Bond Plan, Trading to Resume
5M ago
1011

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >